Concepedia

Roger Strair

RS

Statistics

Publications

41

Citations

2.3K

H-Index

24

Active since

1977

Affiliations

Rutgers Cancer Institute(Current)

Rutgers, The State University of New Jersey

Albert Einstein College of Medicine

Johnson University

The University of Texas MD Anderson Cancer Center

Roger Strair is an author at Rutgers Cancer Institute specializing in medicine, oncology, and life sciences.

ORCID

Publications per year

1977–2021

41

Publications

41

Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

Michael Andreeff, Kevin R. Kelly, Karen Yee et al. · Clinical Cancer Research · 2015 · 353 citations

, , +17

Phase I/II Study of an Anti-CD30 Monoclonal Antibody (MDX-060) in Hodgkin's Lymphoma and Anaplastic Large-Cell Lymphoma

Stephen M. Ansell, Steven M. Horwitz, Andreas Engert et al. · Journal of Clinical Oncology · 2007 · 251 citations

, , +16

A Phase 2 Clinical Trial of Deforolimus (AP23573, MK-8669), a Novel Mammalian Target of Rapamycin Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies

David A. Rizzieri, Eric J. Feldman, John F. DiPersio et al. · Clinical Cancer Research · 2008 · 225 citations

, , +15

miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation

Dale Schaar, Daniel Medina, Dirk F. Moore et al. · Experimental Hematology · 2009 · 128 citations · Full text

, , +16

Effect of a short term fast on the distribution of cytoplasmic albumin messenger ribonucleic acid in rat liver. Evidence for formation of free albumin messenger ribonucleoprotein particles.

Sing Hiem Yap, Roger Strair, David A. Shafritz · Journal of Biological Chemistry · 1978 · 123 citations · Full text

, , +10

1–5 of 41